|
|
|
| Educational Objectives |
|
| This program is accredited for 16 AMA PRA Category 1 Credits™. Upon completion of this program, participant should be able to: |
Day 1:
- Critically analyze the evidence on Vitamin D’s role in cancer
- Recognize the evolving understanding of the human microbiome
- Describe trends in international infectious dermatologic conditions
- Explore evolving new therapies for psoriasis
- Describe the risks, benefits, and side effects of bisphosphonates, especially in dermatology patients on systemic steroid therapy
- Improve performance interpreting dermoscopic images
- Understand and plan treatment options for aging hands
Day 2:
- Distinguish between dermatologic presentations of bioterrorism agents
- Effectively screen and clear patients for dermatologic surgery
- Recognize some diseases that appear in consultative medical dermatology
- Employ evidence-based management of patients on glucocorticoid therapy
- Describe the causes and consequences of immunosenescence
Day 3:
- Describe new evidence regarding viral triggers of psoriasis
- Recognize and properly manage birthmarks that may be markers for systemic malformations
- Distinguish between facts and fallacies regarding microbes in patients with atopic dermatitis
- Effectively plan treatment for difficult wounds using emerging concepts
- Recognize and properly treat simulants of pyoderma gangrenosum
- Effectively diagnose and triage urgent rashes in neonates
|
|
|
Return to Dermatology Foundation Home Page
Printer Friendly Page
|
|
|
|
|
|
